Bezafibrate induces multidrug-resistance P-Glycoprotein 3 expression in cultured human hepatocytes and humanized livers of chimeric mice

Hepatology Research

Volumn 37, Issue 7, 2007, Pages 548-556

  Shoda, Junichi ^a   Okada, Kosuke ^a   Inada, Yoichi ^b   Kusama, Hiroshi ^b   Utsunomiya, Hirotoshi ^c   Oda, Koji ^d   Yokoi, Tsuyoshi ^e   Yoshizato, Katsutoshi ^f   Suzuki, Hiroshi ^g  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Kissei Pharmaceutical K   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e KANAZAWA UNIVERSITY   (Japan)

^f HIROSHIMA UNIVERSITY   (Japan)

^g UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Cholestasis; Fibrate; Human hepatocyte; Human liver; Phospholipid transporter

Indexed keywords

BEZAFIBRATE; MULTIDRUG RESISTANCE PROTEIN 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BILE ACID METABOLISM; CELL CULTURE; CELLULAR DISTRIBUTION; CHIMERA; CHOLANGITIS; CHOLESTASIS; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; INTRAHEPATIC BILE DUCT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

EID: 34249908931     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00069.x     Document Type: Article

References (30)

1. Gatmaitan ZC, Leveille-Webster CR, Arias IM. The biology of the bile canaliculus. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter D, Schafritz DA, eds. The Liver: Biology and Pathobiology, 3rd edn. New York: Raven, 1994; 665-75.
2. Rosario J, Sutherland E, Zaccaro L et al. Ethinylestradiol administration selectively alters liver sinusoidal membrane lipid fluidity and protein composition. Biochemistry 1988; 27: 3939-46.
3. Rigotti A, Marzolo MP, Nervi F. Lipid transport from the hepatocyte into bile. Curr Top Membr 1994; 40: 579-615.
4. Oude Elferink RP, Ottenhoff R, van Wijland M et al. Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. J Clin Invest 1995; 95: 31-8.
5. Smit JJM, Schinkel AH, Oude Elferink RPJ et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993; 75: 451-62.
6. Ruetz S, Gros P. Enhancement of Mdr2-mediated phosphatidylcholine translocation by the bile salt taurocholate. J Biol Chem 1995; 270: 25388-95.
7. Smith AJ, de Vree JML, Ottenhoff R et al. Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in mdr2 (-/-) mice. Hepatology 1998; 28: 530-6.
8. de Vree JM, Jacquemin E, Sturm E et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 1998; 95: 282-7.
9. Dixon PH, Weerasekera N, Linton KJ et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: Evidence for a defect in protein trafficking. Hum Mol Genet 2000; 9: 1209-17.
10. Rosmorduc O, Hermelin B, Boelle PY et al. ABCB4 gene mutation-associated cholelithiasis. Gastroenterology 2003; 125: 452-9.
11. Shoda J, Oda K, Suzuki H et al. Etiological significance of metabolic defects of cholesterol, phospholipid, and bile acid in the liver of patients with intrahepatic calculi. Hepatology 2001; 33: 1194-205.
12. Rosmorduc O, Hermelin B, Poupon R. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol lithiasis. Gastroenterology 2001; 120: 1459-67.
13. Kok T, Bloks VW, Wolters H et al. Peroxisome proliferators-activated receptor α (PPAR α)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. Biochem J 2003; 369: 539-47.
14. Chianale J, Vollrath V, Wielandt AM et al. Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse. Biochem J 1996; 314: 781-6.
15. Kurihara T, Niimi A, Maeda A et al. Bezafibrate in the treatment of primary biliary cirrhosis: Comparison with ursodeoxycholic acid. Am J Gastroenterol 2000; 95: 2990-2.
16. Kubitz R, Huth C, Schmitt M et al. Protein kinase C-dependent distribution of the multidrug resistance protein 2 from the canalicular to the basolateral membrane in human HepG2 cells. Hepatology 2001; 34: 340-50.
17. Shoda J, Inada Y, Tsuji A et al. Bezafibrate stimulates canalicular localization of nbd-labeled phosphatidylcholine in HepG2 Cells by PPARα-mediated redistribution of ABCB4. J Lipid Res 2004; 45: 1813-25.
18. Tateno C, Yoshizane Y, Saito N et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 2004; 165: 901-12.
19. Peters JM, Aoyama T, Burns AM, Gonzalez FJ. Bezafibrate is a dual ligand for PPARalpha and PPARbeta: Studies using null mice. Biochim Biophys Acta 2003; 1632: 80-9.
20. Kjorholt C, Akerfeldt MC, Biden TJ, Laybutt DR. Chronic hyperglycemia, independent of plasma lipid levels, is sufficient for the loss of beta-cell differentiation and secretory function in the db/db mouse model of diabetes. Diabetes 2005; 54: 2755-63.
21. Okada K, Shoda J, Kano M et al. Inchinkoto, an herbal medicine, and its ingredients dually exerts Mrp2/MRP2-mediated choleresis and Nrf2-mediated antioxidative action in rat livers. Am J Physiol 2006 (in press).
22. Shoda J, Miura T, Utsunomiya H et al. Genipin enhances Mrp2 (Abcc2) -mediated bile formation and organic anion transport in rat liver. Hepatology 2004; 39: 167-78.
23. Chiang JYL. Regulation of bile acid synthesis. Front Biosci 1998; 3: D176-D93.
24. Sato R, Inoue J, Kawabe Y, Kodama T, Takano T, Maeda M. Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2. J Biol Chem 1996; 271: 26461-4.
25. Inoue I, Itoh F, Aoyagi S et al. Fibrate and statin psynergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB. Biochem Biophys Res Commun 2002; 290: 131-9.
26. Tugwood JD, Aldridge TC, Lambe KG et al. Peroxisome proliferator-activated receptors: Structures and function. Ann N Y Acad Sci 1996; 804: 252-65.
27. Palmer CN, Hsu MH, Griffin KJ et al. Peroxisome proliferator activated receptor-alpha expression in human liver. Mol Pharmacol 1998; 53: 14-22.
28. Lawrence JW, Li Y, Chen S et al. Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expression. J Biol Chem 2001; 276: 31521-7.
29. Kipp H, Arias IM. Intracellular trafficking and regulation of canalicular ATP-binding cassette transporters. Semin Liver Dis 2000; 20: 339-51.
30. Roglans N, Vazquez-Carrera M, Alegret M et al. Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients. Eur J Clin Pharmacol 2004; 59: 855-61.